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Organelle morphology of the endomembrane system is critical for optimal organelle function. ADP ribosylation factors
(Arfs), a family of small GTPases, are required for maintaining the structure of the Golgi and endosomes. What
determines the discontinuous nature of the endoplasmic reticulum (ER)–Golgi intermediate compartment (ERGIC) as
tubulovesicular clusters is unknown. In search of morphological determinants for the ERGIC, we found that a double
knockdown of Arf1Arf4 induced dynamic ERGIC tubules that connect ERGIC clusters, indicating that the tubules
mediated lateral intraERGIC trafﬁc. Tubule formation was inhibited by an antagonist of group VI calcium-independent
phospholipase A2 (PLA2G6) and by silencing the A isoform of PLA2G6 (PLA2G6-A). Arf1Arf4 depletion altered the
expression of PLA2G6-A splice variants and relocalized PLA2G6-A from the cytosol to ERGIC clusters and tubules,
suggesting that the enzyme became locally active. We show that changes in Arf1 can modulate the activity of PLA2G6-A.
We propose that a concerted action of Arf1, Arf4, and PLA2G6-A controls the architecture of the ERGIC in a way that is
predicted to impact the rate and possibly the destination of cargos. Our ﬁndings have identiﬁed key components in the
molecular mechanism underlying the regulation of tubules in the ERGIC and uncover tubular carriers as tightly
controlled machinery.
INTRODUCTION
The early secretory pathway is formed by the endoplasmic
reticulum (ER), the ER–Golgi intermediate compartment
(ERGIC), and the Golgi, which have strikingly different
structures (Palade, 1975; Bannykh et al., 1996; Appenzeller-
Herzog and Hauri, 2006). The ERGIC consists of a constant
average number of discontinuous long-lived stationary tu-
bulovesicular clusters that stain positive for the type I trans-
membrane lectin ERGIC-53 and for the cytosolic coat protein
(COP) I subunit -COP (Schweizer et al., 1988; Klumperman
et al., 1998; Ben-Tekaya et al., 2005). The ERGIC is equivalent
to the site at which ER-to-Golgi transport of some cargo
proteins and receptors is reversibly blocked at 15°C
(Kuismanen and Saraste, 1989; Schweizer et al., 1990; Lotti et
al., 1992; Klumperman et al., 1998; Blum et al., 2000; Ben-
Tekaya et al., 2005; Simpson et al., 2006). ERGIC stationary
clusters operate as sorting stations of anterograde cargo
directed to the Golgi and retrograde cargo directed to the ER
(Ben-Tekaya et al., 2005). In addition, the stationary clusters
communicate by fusion and ﬁssion and by fast-moving car-
riers, the function of which is unknown (Ben-Tekaya et al.,
2005). Recently, the ERGIC was found to be more complex
than anticipated, including a centrosomal connection that
was proposed to mediate trafﬁc to the recycling endosomes
(Marie et al., 2009; Saraste et al., 2009).
Various drugs affect the morphology of the ERGIC. For
example, treating cells with the fungal metabolite brefeldin
A (BFA) induces cycling proteins to accumulate in the
ERGIC and increases the size of ERGIC clusters (Lippincott-
Schwartz et al., 1990; Fullekrug et al., 1997; Scheel et al., 1997;
Breuza et al., 2004). BFA prevents the activation of ADP
ribosylation factor (Arf) 1 by guanine exchange factors, thus
blocking Arf1 in its guanosine diphosphate-inactive form
(Renault et al., 2003; Zeghouf et al., 2005). This prevents
binding of COPI to membranes (Donaldson et al., 1990;
Scheel et al., 1997). A phenotype similar but not identical to
BFA arises in HeLa cells after Arf1 and Arf4 knockdown.
The double knockdown but not single knockdowns of Arf1
and Arf4 causes ß-COP to disperse throughout the cytosol
(Volpicelli-Daley et al., 2005). In that case, however, dis-
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4130persal of -COP was not reported to coincide with a change
in the morphology of the ERGIC.
Temperature manipulations also can change the architec-
ture of the ERGIC. In cells incubated at 15–16°C and re-
warmed for short times to 37°C, tubules positive for the
ERGIC marker ERGIC-53 are observed, indicating accentu-
ated ERGIC-to-ER retrograde trafﬁc (Lippincott-Schwartz et
al., 1990; Schweizer et al., 1990; Klumperman et al., 1998;
Ben-Tekaya et al., 2005; Simpson et al., 2006). ERGIC tubules
are also observed in cells knocked down for guanine nucle-
otide exchange factor (Szul et al., 2007), in cells overexpress-
ing some cargo proteins or cargo receptors (Blum et al., 2000;
Mironov et al., 2003; Simpson et al., 2006) as well as in cells
expressing Rab1A (Sannerud et al., 2006).
The determinants of ER morphology, as a reticular net-
work (Vedrenne et al., 2005; Hu et al., 2009; Orso et al., 2009),
and of the Golgi, as stacked cisternae (Glick and Nakano,
2009), have been investigated for several years and with
substantial but incomplete success, but those dictating the
discontinuous nature of the ERGIC as a few hundred tubu-
lovesicular clusters are unknown. Here, we show that Arf1,
Arf4, and PLA2G6-A activity are necessary to maintain the
discontinuous morphology of the ERGIC.
MATERIALS AND METHODS
Recombinant pSUPER Vectors
Standard molecular biology protocols were used. Oligonucleotides were from
the Microsynth (Balgach, Switzerland) and enzymes were from New England
Biolabs (Ipswich, MA). Construction of nuclear (nuc)ECFP was done as
follows: 1) introduction of EcoRI and BamHI sites by polymerase chain
reaction (PCR) ampliﬁcation of S6-NLS (Jones et al., 1999b), 2) ligation into
pECFP-C1 (Clontech, Mountain View, CA), 3) addition of SpeI and SacII sites
to the cytomegalovirus promoter-ECFP-NLS sequence, 4) ligation into
TOPO-TA vector (Invitrogen, Carlsbad, CA), 5) ligation into pSUPER vectors
in the antiparallel direction to the H1 promoter to avoid interferences with
short hairpin RNA (shRNA) production, and 6) authentication by DNA
sequencing.
Cell Culture, Transfection, and Knockdown
HeLa cells were grown as described previously (Ben-Tekaya et al., 2005).
FuGENE 6 (Roche Diagnostics, Basel, Switzerland) was used for transfections
and knockdowns. Arf1Arf4 double knockdowns were as described previ-
ously (Volpicelli-Daley et al., 2005). In double knockdown experiments where
two pSUPER vectors were cotransfected, only one of the vectors carried
nucECFP. PLA2G6-A shRNAs were from Sigma-Aldrich (St. Louis, MO).
PLA2G6-A knockdowns were for 48 h. When needed, PLA2G6-A shRNAs
were cotransfected with pDsRedT1 (red ﬂuorescent protein [RFP]) as a trans-
fection marker. This was the case in rewarming experiments because the
endogenous signal of PLA2G6-A was affected by the block and the rewarm-
ing. Myc-tagged mArf1 cDNA was from GeneCopoeia (Rockville, MD). Of
note, mArf1 is resistant to human Arf1 shRNA, although it is identical to
human Arf1 at the protein level. PLA2G6-A long splice variant (L-iPLA2)
transfection was as described previously (Larsson et al., 1998).
Immunoﬂuorescence Microscopy
Immunoﬂuorescence microscopy was as described previously (Ben-Tekaya et
al., 2005). The antibodies used were as follows: mouse monoclonal antibodies
against CLIMP-63 (Schweizer et al., 1993), -tubulin (Kreis, 1987), myc (Itin et
al., 1995), and GPP130 (Linstedt et al., 1997) and rabbit polyclonal antibodies
against PLA2G6-A (H-120; Santa Cruz Biotechnology, Santa Cruz, CA), and
Sec31 (Shugrue et al., 1999). H-120 antibody is predicted to detect an epitope
at the N terminus of all PLA2G6-A splice variants. Phalloidin was from
Invitrogen (Carlsbad, CA). Bright ﬁeld images were taken with a DM5000B
(63  1.32 numerical aperture [NA] oil lens; Leica, Wetzlar, Germany), and
confocal images were taken with an SPE (63  1.3 NA oil lens; Leica).
Unbiased quantiﬁcation of GFP-ERGIC-53 tubules was as follows: 1) selection
of cells with nucECFP signal or with RFP signal, 2) scoring of cells with
tubules if they have at least one long peripheral GFP-ERGIC-53 tubule, and 3)
blind tests to minimize subjective analyses; 100% represents the total of
counted cells. Unless stated otherwise, data are presented as mean  SD of at
least three independent experiments. Statistical analysis was performed with
either a Student’s t test or with a Wilcoxon rank sum test using MATLAB
software (The MathWorks, Natick, MA).
Live Cell Imaging, Transport Blocks, and Drug Treatment
Imaging and processing were as described previously (Ben-Tekaya et al.,
2005). Here, ﬁlters were applied to Supplemental Movies 2, 3, and 4. Block at
16°C and rewarming were as described previously (Ben-Tekaya et al., 2005).
Nocodazole was from Fluka (Buchs, Switzerland); ONO-RS-082 was from
BIOMOL International (Plymouth Meeting, PA); pyrrolidine-1 was from Cal-
biochem (San Diego, CA); and bromoenolactone (BEL) was from BIOMOL
International. Egg l--lysophosphatidylcholine (LPC) was from Sigma-Aldrich
(St. Louis, MO). All the drugs were diluted in HEPES-buffered Ham’s F12
medium (Ben-Tekaya et al., 2005). LPC was introduced into cells as follows. A
40 mM LPC stock solution diluted in chloroform was dried by blowing it with
nitrogen gas. It was then mixed with 1 mg/ml fatty acid-free bovine serum
albumin (Sigma-Aldrich) diluted in HEPES-buffered Ham’s F12 medium to a
ﬁnal concentration of 25 M LPC. Cells were treated with this mixture
combined with 50 M BEL for 20 min at 37°C.
Immunoblotting and Immunoprecipitation
Arf1 and Arf4 immunoblotting was described previously (Volpicelli-Daley et
al., 2005). Quantiﬁcation of knockdown efﬁciency was with the Odyssey
program (Li-Cor Biosciences, Lincoln, NE). PLA2G6-A and myc immunoblot-
ting was as follows. Cells were harvested at 4°C in lysis buffer (25 mM
Tris-HCl, pH 7.6, 150 mM NaCl, 1% Na deoxycholate, and 1% NP40) supple-
mented with protease inhibitors. Lysates were then centrifuged 15 min at
14,000  g at 4°C. Equal amounts of protein per lane were separated by
SDS-polyacrylamide gel electrophoresis, immunoblotted, and visualized by
enhanced chemiluminescence (Alpha Innotech, San Leandro, CA). PLA2G6-A
was detected with P-19 antibody (Santa Cruz Biotechnology), the myc tag
with anti-myc antibody (Itin et al., 1995), Arf4 with R-891 (Cavenagh et al.,
1996), and Arf1 with either R-1026 (Cavenagh et al., 1996) or with a peptide
antibody (Skippen et al., 2002). Quantiﬁcation was with Image Pro (Media
Cybernetics, Bethesda, MD). For the immunoprecipitation, cells were trans-
fected or not with mArf1, and supernatants of cell lysates were incubated
with anti-PLA2G6-A (H-120) or anti-L-iPLA2 (T-14; Santa Cruz Biotechnol-
ogy) coupled to protein G-Sepharose beads (Sigma-Aldrich). Beads were then
washed with 1 phosphate-buffered saline and immunoblotted as described
above.
RESULTS
We studied the role of Arf1Arf4 in controlling the ERGIC
by using ﬂuorescence microscopy and a knockdown ap-
proach. Because this method deals with single cells, proper
detection of individual cells was required. To this end, we
cloned into pSUPER vectors ECFP in frame with a nuclear
localization signal (nucECFP). HeLa cells stably expressing
GFP-ERGIC-53 transfected with Arf1Arf4 shRNAs exhib-
ited 80% reduction of both Arf1 and Arf4 (Figure 1A)
similarly to shRNAs not carrying the nuclear indicator
(Volpicelli-Daley et al., 2005), suggesting that nucECFP did
not impair the knockdown efﬁciency. As predicted, nu-
cECFP localized to the nucleus and to structures reminiscent
of nucleoli (Figure 1B). nucECFP expression did not affect
the localization of GFP-ERGIC-53 in control pSUPER-trans-
fected cells, suggesting that this indicator was appropriate to
identify single transfected cells.
Arf1Arf4 Silencing Induces Tubulation of the ERGIC
Fixed Arf1Arf4 knockdown cells exhibited extensive GFP-
ERGIC-53 tubules (Figure 1B). A tubule was deﬁned as a
membrane structure 5 m in length. Tubules seemed to
connect peripheral ERGIC clusters. More than 80% of double
knockdown cells showed GFP-ERGIC-53 tubules. On aver-
age, only 19% of control cells, 27% of Arf1 knockdown cells
and 14% of Arf4 knockdown cells exhibited tubules (Sup-
plemental Figure S1A), consistent with the previous ﬁndings
that single knockdowns of Arf1 or Arf4 have no noticeable
phenotype (Volpicelli-Daley et al., 2005). Upon Arf1Arf4
depletion, tubules were observed in two HeLa cell lines
stably expressing GFP-ERGIC-53 as well as in parental HeLa
cells stained for endogenous ERGIC-53 (Supplemental Fig-
ure S1B), indicating that the stable cells and parental HeLa
cells behave indistinguishably. Thus, we think that tubula-
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tuated in cells depleted of Arf1Arf4.
Video microscopy of double knockdown cells showed that
GFP-ERGIC-53 tubules were continuously elongating and
shrinking (Figure 1C and Supplemental Movie 1), suggest-
ing that a tubule was a continuous entity rather than a string
of vesicles. Occasionally, tubules elongated toward periph-
eral spots (Figure 1C), conﬁrming our observation with ﬁxed
cells that they connect ERGIC clusters. Tracking peripheral
ERGIC spots revealed that Arf1Arf4 knockdown did not
alter the ﬁssion and fusion activity of GFP-ERGIC-53 sta-
tionary clusters (Supplemental Movie 2), and fast-moving
carriers were still observed (Supplemental Movie 3). We
conclude that Arf1Arf4 act synergistically in cells to regu-
late the formation of ERGIC tubules.
To further characterize the tubules, we double labeled
GFP-ERGIC-53 with markers of the secretory pathway.
Arf1Arf4 knockdown did not affect the morphology of ER
or ER export sites (ERESs; Figure 1, D and E). GFP-ERGIC-53
tubules did not colocalize with the ER marker CLIMP-63
(Figure 1D), suggesting that these tubules were not ER-
derived. ERESs, revealed by Sec31 staining, occasionally
localized to GFP-ERGIC-53 tubules (Figure 1E). This overlap
was fortuitous because localization of Sec31 spots on a tu-
bule was random, and tubules with no Sec31 staining were
observed. A previous study of Arf1Arf4 knockdown re-
ported cis-Golgi GM130-positive tubules (Volpicelli-Daley et
al., 2005). However, GM130 can rapidly cycle between cis-
Golgi and ERGIC (Marra et al., 2001), compromising the
value of GM130 as a speciﬁc cis-Golgi marker. As a genuine
cis-Golgi marker, we thus used the membrane protein
GPP130 (Linstedt et al., 1997). In Arf1Arf4 knockdown
cells, GPP130 showed an unchanged Golgi pattern, and no
colocalization with GFP-ERGIC-53 tubules was observed
Figure 1. Arf1Arf4 double knockdown in-
duces ERGIC tubules. (A) The protein level of
both Arf1 and Arf4 (lower arrowheads) was
reduced to 20% in HeLa cells stably express-
ing GFP-ERGIC-53 and cotransfected with
Arf1Arf4 shRNAs. Lysates were blotted with
anti-Arf1, anti-Arf4, or as a loading control
with anti-tubulin. (B) Arf1Arf4 knockdown
induces GFP-ERGIC-53-positive tubules (ar-
rows), which connect ERGIC clusters (bottom
panel, ﬁlled arrowheads). Such connections are
restricted to some ERGIC clusters in knock-
down cells and are absent in control cells (bot-
tom panel, empty arrowheads). Bottom panels
are magniﬁcations of the highlighted regions.
(C) Time series of live cells imaged every 3s
(from Supplemental Movie S1) where station-
ary ERGIC clusters connected (ﬁlled arrow-
heads) or not (empty arrowheads) by tubules
are observed. The bottom panel is a magniﬁ-
cation. (D–G) Confocal sections of knockdown
cells as described in B stained for CLIMP-63
(D), Sec31 (E), GPP130 (F), or -tubulin (G).
GFP-ERGIC-53 do not colocalize with CLIMP-
63, Sec31, or GPP130 (empty arrowheads in
D-F). In some instances GFP-ERGIC-53-posi-
tive tubules colocalize with Sec31 spots or
-tubulin tubules (ﬁlled arrowheads in E and
G). Insets and bottom panels are a magniﬁca-
tion of the highlighted regions. pSUPER and
Arf1 shRNA vectors carry nucECFP. Trans-
fected cells were identiﬁed by nucECFP signal.
Bars, 5 m.
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lation of ERGIC clusters cannot be resolved by light micros-
copy, we focused our further analysis on peripheral ERGIC
tubules at considerable distance from the Golgi.
In living cells, tubules were dynamic, suggesting that they
moved along the cytoskeleton. To test this, we stained
Arf1Arf4 knockdown cells for tubulin and actin. The dis-
tribution of microtubules (Figure 1G and Supplemental Fig-
ure S1C) and the actin cytoskeleton (Supplemental Figure
S1D) was unchanged in these cells. GFP-ERGIC-53 tubules
aligned with tubulin (Figure 1G and Supplemental Figure
S1C) but not with actin (Supplemental Figure S1D). Treat-
ment with nocodazole, a microtubule-disruptive drug, in-
hibited GFP-ERGIC-53 tubules, whereas no inhibition was
observed with the actin-disrupting chemical latrunculin B
(Supplemental Figure S1, C and D). These results are most
consistent with the conclusion that the ERGIC tubules that
arise in cells depleted of Arf1Arf4 move along microtu-
bules.
To understand the role of ERGIC tubules upon Arf1Arf4
knockdown, we studied a marker of the secretory pathway,
ssDsRed, in which an N-terminal signal sequence was added
to DsRed (Ben-Tekaya et al., 2005). ssDsRed accumulates in
the ER and ERGIC when cells are cooled to 16°C and is
sorted into anterograde transport carriers directed to the
Golgi upon rewarming to 37°C (Ben-Tekaya et al., 2005). This
is clearly the result of a sorting event and not fusion of
ERGIC with other organelles as the ERGIC clusters persist
upon rewarming. In control pSUPER-transfected cells (Fig-
ure 2A and Supplemental Movie 4) or Arf1Arf4-depleted
Figure 2. Arf1Arf4 mediate trafﬁc between
ERGIC peripheral clusters. Time series of live
cells extracted from Supplemental Movies S4
and S5. Control and knockdown cells were as
described in Figure 1B. They were in addition
transfected with ssDsRed and incubated3ha t
16°C followed by a shift to 37°C. Images were
acquired every 3 s. (A) Arrows point to sorting
ERGIC clusters. Arrowheads point to dual-la-
beled tubules. Insets are magniﬁcations. (B)
Arrows, dual-labeled tubules; dashed arrows,
ERGIC clusters sorting ssDsRed without being
consumed; arrowheads, ERGIC tubules devoid
of ssDsRed. Insets, magniﬁcation of the high-
lighted region. (C) Arrows point to dual-la-
beled tubules connecting ERGIC clusters. Ar-
rowheads point to ERGIC clusters. (D) Dashed
arrows point to ssDsRed-positive anterograde
carrier moving to the Golgi (G). Bars, 5 m.
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warmed to 37°C, ssDsRed localized to ER and ERGIC clus-
ters. Occasionally in control cells, dual-labeled dynamic tu-
bules connecting peripheral ERGIC clusters were observed
(Figure 2A). As the rewarming progressed, ERGIC clusters
segregated ssDsRed without being consumed by the sorting
event. In Arf1Arf4-depleted cells, ssDsRed localized to
tubules virtually all positive for GFP-ERGIC-53 (Figure 2B).
Conversely, not all GFP-ERGIC-53 tubules were positive for
ssDsRed. We assume that the ssDsRed-negative tubules rep-
resent ERGIC-to-ER retrograde trafﬁc (Ben-Tekaya et al.,
2005). Double-labeled tubules emerging from a peripheral
ERGIC cluster were often directed toward another ERGIC
cluster with which they seemed to fuse (Figure 2C). These
tubules showed no substantial movement to the jux-
tanuclear Golgi region (Supplemental Movie 5). At later
rewarming times, ERGIC clusters segregated ssDsRed car-
riers that moved to the Golgi (Figure 2D). Like in control
cells, the sorting event did not consume ERGIC stationary
clusters (Figure 2B and Supplemental Movie 5). Together,
these observations indicate that cargo in the ERGIC can
move between ERGIC clusters via tubules that are more
numerous and persistent in Arf1Arf4 knockdown cells.
Role of Phospholipase A2 in ERGIC Tubulation
Tubulation in the early secretory pathway is controlled by
PLA2 activity (de Figueiredo et al., 2000), probably due to the
generation of lysophospholipids, fusogenic inverted cone-
Figure 3. ERGIC tubules induced by Arf1Arf4 double knockdown are sensitive to some PLA2 antagonists. Cells were processed as
described in Figure 1D and were either untreated (A) or treated for 20 min with ONO-RS-082 (B), pyrrolidine (C), BEL (D), or BEL
supplemented with LPC (E). Bar, 5 m. Insets are magniﬁcations of the highlighted regions. (F) 100% represents the total number of cells
counted. Results are shown as mean  SD of three to nine independent experiments. p values were calculated with a Wilcoxon rank test. The
white bar represents pSUPER-transfected cells. Black bars represent Arf1Arf4 knockdown cells.
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lipid bilayer (Brown et al., 2003). To date two PLA2 groups
were suggested to function in the early secretory pathway:
group IV calcium Ca2-dependent PLA2 (PLA2G4, also
named cPLA2) and group VI Ca2-independent PLA2
(PLA2G6, also named iPLA2) (Brown et al., 2003; Ghosh et
al., 2006). To explore whether the tubules observed in re-
sponse to Arf1Arf4 silencing were due to these PLA2,w e
treated knockdown cells with ONO-RS-082, an inhibitor of
these activities. ONO-RS-082 reduced the number of ERGIC
tubules (Figure 3B) as well as the percentage of cells with
ERGIC tubules (Figure 3F), suggesting that tubules were due
to PLA2. PLA2G4 has six members named A–E. Only
PLA2G4-A (also named cytosolic PLA2) can associate with
the Golgi (Evans et al., 2001) and was shown to control Golgi
morphology and intracellular trafﬁc (Choukroun et al., 2000;
San Pietro et al., 2009). To determine whether the tubules
were due to PLA2G4-A activity, we treated Arf1Arf4
Figure 4. Arf1Arf4 depletion affects PLA2G6-A localization, and PLAG6-A silencing inhibits ERGIC tubules. (A) Control cells were treated
as described in Figure 1B and stained with anti-PLA2G6-A. Arrowheads point to PLA2G6-A spots not colocalizing with ERGIC clusters. (B)
Arf1Arf4 knockdown cells were treated as described in Figure 1D. Arrowheads point to PLA2G6-A spots and tubules colocalizing with
ERGIC clusters and tubules. Right panels are magniﬁcations of the highlighted regions. (C) Equal amounts of proteins from cell lysates were
blotted with anti-PLA2G6-A (top) or with anti-Arf1 (bottom). (D) Quantiﬁcation of the ratio L-iPLA2 to ankyrin-iPLA2. Values from
Arf1Arf4 knockdown cells were normalized to pSUPER-transfected cells, the values of which were set to 1. Results are shown as mean 
SD from four independent experiments. p values were calculated using a Wilcoxon rank test. (E and F) Knockdown cells as described in B
were transfected with control (E) or L-iPLA2 (F) shRNAs. Bottom panels are magniﬁcations of the highlighted regions. Bars, 5 m.
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inhibits the activity of some PLA2G4 members without af-
fecting the activity of PLA2G6 (Ghomashchi et al., 2001).
Clearly, 20 M pyrrolidine did not inhibit ERGIC tubules
(Figure 3C) and did not decrease the percentage of cells with
GFP-ERGIC-53 tubules (Figure 3F). Because HeLa cells have
high levels of PLA2G4-A (Grewal et al., 2005), we increased
the concentration of pyrrolidine up to 160 M. Even at this
high concentration, no effect on ERGIC tubules was ob-
served (Supplemental Figure S2), suggesting that PLA2G4-A
activity is not controlling ERGIC tubulation in Arf1Arf4
knockdown cells.
BEL, a membrane permeable antagonist with a 1000-fold
selectivity for PLA2G6 over PLA2G4 (Ackermann et al.,
1995), inhibits tubules in the early secretory pathway (de
Figueiredo et al., 2000). Treatment of Arf1Arf4 knockdown
cells with 50 M BEL inhibited ERGIC tubules (Figure 3D)
and reduced the percentage of cells with GFP-ERGIC-53
tubules down to 32% (Figure 3F). This percentage was
similar to that of pSUPER-transfected cells (28%), suggest-
ing that tubules induced by Arf1Arf4 depletion were de-
pendent upon PLA2G6 activity.
LPC, a product of PLA2G6, bypasses the inhibition by
BEL (Fensome-Green et al., 2007). To test whether this is also
the case in Arf1Arf4-depleted cells, we supplemented
BEL-treated cells with LPC. BELLPC treatment restored
GFP-ERGIC-53 tubules (Figure 3E), and 63% of Arf1Arf4
depleted cells treated with BELLPC showed GFP-ERGIC-53
tubules (Figure 3F). This percentage was similar to untreated
knockdown cells (69%), indicating that upon Arf1Arf4
silencing, a product of PLA2G6 is necessary to induce
ERGIC tubulation.
To pinpoint the PLA2G6 enzyme controlling ERGIC tu-
bulation in vivo, we localized the endogenous A isoform of
PLA2G6 (PLA2G6-A, also named iPLA2). The B isoform
(also named iPLA2) localizes to peroxisomes (Yang et al.,
2003), ER, and mitochondria and responds to oxidative
stress (Kinsey et al., 2007), rendering it less likely to control
ERGIC tubulation upon Arf1Arf4 depletion. In control
cells, PLA2G6-A localized to peripheral puncta and to the
Golgi region where it colocalized with juxtanuclear GFP-
ERGIC-53 (Figure 4A). In these cells, peripheral PLA2G6-A
puncta were largely distinct from ERGIC clusters. In
Arf1Arf4 knockdown cells, PLA2G6-A accumulated in the
juxtanuclear region and also localized to puncta (Figure 4B).
Strikingly, in these cells PLA2G6-A puncta colocalized
with GFP-ERGIC-53 clusters. In addition, PLA2G6-A as-
sociated with extensions that partially overlapped with
GFP-ERGIC-53 tubules, suggesting that PLA2G6-A acts at
these sites.
PLA2G6A has multiple splice variants: long variants
(L-iPLA2) and short variants (ankyrin-iPLA2) (Larsson et al.,
1998). If PLA2G6-A activity is high, ankyrin-iPLA2 protein
levels are reduced. Thus, the L-iPLA2/ankyrin-iPLA2 ratio is
Figure 5. mArf1 rescues Arf1Arf4 knock-
down and interacts with PLA2G6-A. (A)
Arf1Arf4 knockdown cells as described in
Figure 1D were transfected with mArf1 and
stained with anti-myc. (B) Cells as described in
A mock transfected. Insets are magniﬁcations
of GFP-ERGIC-53 channel in the highlighted
regions. Arrowheads point to tubules. Bar, 5
m. (C) Knockdown cells were counted as de-
scribed in Figure 3F. Data are represented as
mean  SD from four to ﬁve independent ex-
periments. The p value was calculated with a
Wilcoxon rank test. (D) Same immunoblots as
shown in Figure 4C with the rescue condition
in addition. (E) Quantiﬁcation of the ratio L-
iPLA2 to ankyrin-iPLA2 as described in Figure
4D. Results are shown as mean  SEM from
four to eight independent experiments. p val-
ues were calculated using a Student’s t test. (F)
Cells transfected () or not () with mArf1
were lysed and immunoprecipitated with anti-
PLA2G6-A (IP iPLA2) and blotted with anti-
PLA2G6-A (top) or anti-myc (bottom). The to-
tal lysate (1%) is shown as a loading control.
(G) Cells were processed as described in F and
immunoprecipitated with anti-L-iPLA2 anti-
body (IP L-iPLA2). They were then immuno-
blotted as described in F. (H) Cells as described
in F were immunoprecipitated with anti-L-
iPLA2 antibody or as a negative control with
anti-myc antibody. They were then immuno-
blotted with anti-PLA2G6-A (top) or anti-Arf1
(bottom).
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bour, 2004; Poulsen et al., 2007). We visualized L-iPLA2 and
ankyrin-iPLA2 expression by Western blotting. Figure 4C
shows that ankyrin-iPLA2 was reduced in Arf1Arf4-de-
pleted cells. The L-iPLA2/ankyrin-iPLA2 ratio was, on av-
erage, approximately threefold higher in knockdown cells
(Figure 4D), indicating that PLA2G6-A activity was in-
creased upon Arf1Arf4 silencing.
L-iPLA2 overexpression induces PLA2G6-A activity
(Larsson et al., 1998). We hypothesized that L-iPLA2
knockdown would decrease PLA2G6-A activity, and we
tested whether L-iPLA2 controls ERGIC tubules. In cells
depleted for L-iPLA2 and stained with an antibody rec-
ognizing all PLA2G6-A splice variants, PLA2G6-A ﬂuo-
rescence was reduced (Figure 4F). Triple transfection with
Arf1Arf4 shRNAs and control shRNA did not affect
ERGIC tubules (Figure 4E). L-iPLA2 depletion inhibited
ERGIC tubules in Arf1Arf4 knockdown cells (Figure 4F
and Supplemental S3) and signiﬁcantly reduced the per-
centage of cells with GFP-ERGIC-53 tubules (Supplemen-
tal Figure S3B), indicating that tubules are controlled by
PLA2G6-A activity.
Figure 6. PLA2G6-A controls tubulation of the ERGIC under conditions where Arf1Arf4 are not depleted. (A) HeLa cells stably expressing
GFP-ERGIC-53 were incubated or not at 16°C for 3 h and rewarmed or not in the presence or absence of BEL. Cells were then stained with
anti-PLA2G6-A. Arrows point to GFP-ERGIC-53 tubules. Filled arrowheads point to PLA2G6-A spots colocalizing with ERGIC clusters.
Empty arrowheads indicate PLA2G6-A spots connected to ERGIC tubules. Bottom panels are magniﬁcations of the highlighted regions. (B)
Cells were cotransfected with pDsRedT1 (RFP) and either a control shRNA or a shRNA targeting PLA2G6-A. Cells were then rewarmed from
16°C as described above. PLA2G6-A knockdown cells were identiﬁed by RFP signal. The arrowhead points to ERGIC tubules. Insets are
magniﬁcations of GFP-ERGIC-53 channel in the highlighted regions. (C) PLA2G6-A knockdown cells treated as described in B were counted
as described in Figure 3F. Data are represented as mean  SD from ﬁve to six experiments. The p value was calculated using a Student’s
t test. (D) Cells were either mock transfected or transfected with L-iPLA2. Arrows point to GFP-ERGIC-53 tubules. Arrowheads point
to PLA2G6-A spots localizing to ERGIC clusters and connected to ERGIC tubules. Insets are magniﬁcations of the highlighted regions.
Bars, 5 m.
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we attempted to rescue normal ERGIC morphology after
Arf1Arf4 depletion. Overexpression of mouse Arf1
(mArf1) in Arf1Arf4 knockdown cells decreased ERGIC
tubules threefold (Figure 5, A–C), indicating that mArf1
rescues Arf1Arf4 knockdown and thus mirrors an Arf4
single knockdown, which has no tubulation phenotype
(Supplemental Figure S1A) (Volpicelli-Daley et al., 2005). We
also tested whether mArf1 expression restores PLA2G6-A
activity, which would be expected if Arf1Arf4 and
PLA2G6-A were linked. Figure 5D shows that ankyrin-
iPLA2 level was increased in these cells. Quantiﬁcation
showed that expression of mArf1 reduces the L-iPLA2/
ankyrin-iPLA2 ratio back to control levels (Figure 5E), sug-
gesting that mArf1 restores PLA2G6-A activity that in turn
decreases ERGIC tubules. We hypothesized that Arf1 regu-
lates PLA2G6-A activity by binding to it and tested whether
Arf1 interacts with PLA2G6-A. Coimmunoprecipitation in-
deed showed that endogenous PLA2G6-A (Figure 5F) and
particularly endogenous L-iPLA2 can pull down a fraction of
both mArf1 (Figure 5G) and endogenous Arf1 (Figure 5H).
Tubule formation at the ERGIC is not restricted to cells
depleted of Arf1Arf4. We and others have shown previ-
ously that in cells blocked at 15–16°C for a few hours and
rewarmed brieﬂy to 37°C, ERGIC tubules are generated
(Lippincott-Schwartz et al., 1990; Schweizer et al., 1990;
Klumperman et al., 1998; Ben-Tekaya et al., 2005; Simpson et
al., 2006). These tubules move between ERGIC clusters and
mediate recycling from the ERGIC to the ER (Ben-Tekaya et
al., 2005). To test whether these tubules also depend on
PLA2G6, we stained cells blocked at 16°C and rewarmed to
37°C for 5 min with anti-PLA2G6-A antibody. As shown in
Figure 6A, in cells blocked at 16°C PLA2G6-A localized
more often to ERGIC clusters than in control cells. Impor-
tantly, PLA2G6-A spots were observed on ERGIC tubules in
cells rewarmed to 37°C. When cells were treated with BEL
during the rewarming, no GFP-ERGIC-53 tubules were de-
tected, in line with what was reported previously (de
Figueiredo et al., 2000) and suggesting that trafﬁc out of the
ERGIC is mediated by PLA2G6-A activity. To corroborate
this suggestion, we performed a 16°C/rewarming experi-
ment in cells knocked down for PLA2G6-A. Figure 6B shows
that, contrary to control cells that exhibit long tubules,
PLA2G6-A knockdown inhibits ERGIC tubules in cells re-
warmed from 16°C. Quantiﬁcation conﬁrmed these obser-
vations and revealed that upon PLA2G6-A depletion, the
percentage of cells with ERGIC tubules was signiﬁcantly
decreased (Figure 6C). If appearance of ERGIC tubules is
indeed controlled by PLA2G6-A, as our data indicate, then
overexpression of L-iPLA2should induce at least some tubu-
lation of the ERGIC. Figure 6D shows that cells overexpress-
ing L-iPLA2 indeed exhibit GFP-ERGIC-53 positive tubules
that are positive for PLA2G6-A spots.
DISCUSSION
These and previous ﬁndings (Ben-Tekaya et al., 2005) show
that ERGIC clusters are relatively stable entities that com-
municate by means of dynamic tubules (Figure 7). These
ERGIC tubules are transient, and their formation is under
regulation by both PLA2G6-A and Arf family GTPases. An
increase in PLA2G6-A activity at ERGIC membranes leads to
local changes in lipid composition, probably including in-
creases in LPC. This leads to the formation of tubules that
connect ERGIC clusters and through which cargo can move
(Figure 7B). The ERGIC tubules were found to align with
microtubules and depend upon microtubules for their for-
mation. We propose that the role of these tubules is to direct
cargo, quickly and efﬁciently, to ERGIC clusters where cargo
sorting can still occur. This could serve either to help equil-
ibrate the composition of ERGIC clusters and their cargos
throughout the cell or perhaps to more efﬁciently move
cargos to clusters that are more actively engaged in sorting
of cargos. Such a model suggests that under normal condi-
tions, Arf1Arf4 together regulate PLA2G6-A activity,
thereby promoting the more discontinuous nature of ERGIC
clusters (Figure 7A). Arf1 and Arf4 were reported to localize
to the ERGIC (Chun et al., 2008), consistent with the notion
that they function in this compartment, although until now
it was widely assumed that their function there was primar-
ily to recruit COPI. Indeed, because Arf1Arf4 silencing
was shown to alter COPI recruitment to the early secretory
pathway (Volpicelli-Daley et al., 2005), it will probably prove
interesting in future studies to determine whether COPI
plays any role in the regulation of ERGIC tubulation. Such a
role may be difﬁcult to dissect or reconcile with its role in
ERGIC to cis-Golgi trafﬁc. However, because Arfs have been
found to regulate both adaptor recruitment and changes in
lipid-metabolizing enzymes at other sites, one could specu-
late that tubulation is a viable cellular alternative to carrier
biogenesis that is controlled by Arf activities. Our data do
not give a clear explanation of which forms of Arf1 and Arf4
control PLA2G6-A activity and how they would do so.
Because active PLA2G6-A is thought to be a homotetramer
(Ackermann et al., 1994), one could speculate that Arf1Arf4
inhibit PLA2G6-A tetramerization by sequestering L-iPLA2
monomers. We think that this function is independent of the
Figure 7. Model of how Arf1, Arf4, and
PLA2G6-A control ERGIC morphology. (A)
Under steady-state conditions, ERGIC clusters
(yellow) sort anterograde cargo (red) into an-
terograde carriers (AC) directed to the Golgi
(red arrows) from retrograde cargo (green) into
retrograde carriers (RC) directed to the ER
(green arrows). Arf1 binds to PLA2G6-A, thus
suppressing generation of ERGIC tubules. (B)
Upon Arf1Arf4 knockdown (or during re-
warming from a 16°C block), PLA2G6-A be-
comes activated and changes the lipid compo-
sition of ERGIC membranes leading to tubules
connecting ERGIC clusters. Cargo is trans-
ported via these tubules to ERGIC clusters that
are still sorting-competent. ERGIC tubules
move along microtubules (MT).
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interaction of Arf1 with phospholipase D (Jones et al., 1999a).
Effects of phospholipases on the secretory pathway were
long believed to be indirect because the products of phos-
pholipases stimulate various signal transduction pathways.
However, recent ﬁndings point to direct effects of PLA2 and
PLA1 (Morikawa et al., 2009; San Pietro et al., 2009; Schmidt
and Brown, 2009), suggesting that different phospholipases
control speciﬁc transport steps in the early secretory path-
way. Here, we provide novel evidence for the involvement
of PLA2G6-A in controlling the architecture of the ERGIC.
Our ﬁndings indicate that in the ERGIC, a tight regulation of
tubules is achieved through the interplay between Arf GT-
Pases and PLA2G6-A. Such regulation might be an efﬁcient
way to ﬂexibly cope with changes in the demands of mem-
brane trafﬁc.
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